{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:40:04Z","timestamp":1790048404898,"version":"4.0.1"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2015,10,14]],"date-time":"2015-10-14T00:00:00Z","timestamp":1444780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0139740","type":"journal-article","created":{"date-parts":[[2015,10,14]],"date-time":"2015-10-14T18:13:24Z","timestamp":1444846404000},"page":"e0139740","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Epigenetic Alterations in Fanconi Anaemia: Role in Pathophysiology and Therapeutic Potential"],"prefix":"10.1371","volume":"10","author":[{"given":"H\u00e9lio","family":"Belo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno A.","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Porto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Minguillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Barbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Coutinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Casado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Benedito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hema","family":"Saturnino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Em\u00edlia","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan A.","family":"Bueren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Surralles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,10,14]]},"reference":[{"issue":"1\u20132","key":"ref1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mrfmmm.2009.01.013","article-title":"Fanconi anemia and its diagnosis","volume":"668","author":"AD Auerbach","year":"2009","journal-title":"Mutat Res"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1158\/2159-8290.CD-14-1156","article-title":"Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype","volume":"5","author":"SL Sawyer","year":"2015","journal-title":"Cancer Discov"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1182\/asheducation-2011.1.492","article-title":"Fanconi anemia","volume":"2011","author":"J Soulier","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"265790","DOI":"10.1155\/2012\/265790","article-title":"Disrupted Signaling through the Fanconi Anemia Pathway Leads to Dysfunctional Hematopoietic Stem Cell Biology: Underlying Mechanisms and Potential Therapeutic Strategies","volume":"2012","author":"A Geiselhart","year":"2012","journal-title":"Anemia"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrc1279","article-title":"The history of cancer epigenetics","volume":"4","author":"AP Feinberg","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"ref6","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2174\/156800909790192428","article-title":"Epigenetic therapy: histone acetylation, DNA methylation and anti-cancer drug discovery","volume":"9","author":"A Ganesan","year":"2009","journal-title":"Curr Cancer Drug Targets"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.hoc.2010.02.007","article-title":"Epigenetic changes in the myelodysplastic syndrome","volume":"24","author":"JP Issa","year":"2010","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.cell.2007.01.029","article-title":"The epigenomics of cancer","volume":"128","author":"PA Jones","year":"2007","journal-title":"Cell"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1053\/j.seminoncol.2008.04.008","article-title":"Epigenetics in acute myeloid leukemia","volume":"35","author":"C Plass","year":"2008","journal-title":"Semin Oncol"},{"issue":"7046","key":"ref10","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/nature03672","article-title":"Global histone modification patterns predict risk of prostate cancer recurrence","volume":"435","author":"DB Seligson","year":"2005","journal-title":"Nature"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"214143","DOI":"10.1155\/2011\/214143","article-title":"Myelodysplastic syndrome and histone deacetylase inhibitors: "to be or not to be acetylated"?","volume":"2011","author":"S Stintzing","year":"2011","journal-title":"J Biomed Biotechnol"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.biocel.2008.10.006","article-title":"Epigenetic therapy of leukemia: An update","volume":"41","author":"N Jain","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nm852","article-title":"Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors","volume":"9","author":"T Taniguchi","year":"2003","journal-title":"Nat Med"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1053\/j.seminhematol.2007.11.007","article-title":"DNA methyltransferase and histone deacetylase inhibitors in the treatment of myelodysplastic syndromes","volume":"45","author":"EA Griffiths","year":"2008","journal-title":"Semin Hematol"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1158\/0008-5472.CAN-04-0245","article-title":"Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer","volume":"64","author":"G Narayan","year":"2004","journal-title":"Cancer Res"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4161\/cbt.5.3.2380","article-title":"Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway","volume":"5","author":"Z Wang","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1756-8722-2-31","article-title":"Vorinostat in solid and hematologic malignancies","volume":"2","author":"D Siegel","year":"2009","journal-title":"J Hematol Oncol"},{"issue":"26","key":"ref18","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1182\/blood-2009-05-222414","article-title":"TLR8-dependent TNF-(alpha) overexpression in Fanconi anemia group C cells","volume":"114","author":"SM Vanderwerf","year":"2009","journal-title":"Blood"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"e53766","DOI":"10.1371\/journal.pone.0053766","article-title":"Vorinostat induces apoptosis and differentiation in myeloid malignancies: genetic and molecular mechanisms","volume":"8","author":"G Silva","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.canlet.2009.01.002","article-title":"Development of vorinostat: current applications and future perspectives for cancer therapy","volume":"280","author":"VM Richon","year":"2009","journal-title":"Cancer Lett"},{"issue":"23","key":"ref21","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1200\/JCO.2005.05.4171","article-title":"DNA repair pathways in clinical practice: lessons from pediatric cancer susceptibility syndromes","volume":"24","author":"RD Kennedy","year":"2006","journal-title":"J Clin Oncol"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"578","DOI":"10.2174\/138161213804581918","article-title":"Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectives","volume":"19","author":"F Andreoli","year":"2013","journal-title":"Curr Pharm Des"},{"issue":"17","key":"ref23","doi-asserted-by":"crossref","first-page":"8462","DOI":"10.1158\/0008-5472.CAN-06-0293","article-title":"Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers","volume":"66","author":"J Rodriguez","year":"2006","journal-title":"Cancer Res"},{"issue":"11","key":"ref24","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1158\/1078-0432.CCR-08-2383","article-title":"DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer","volume":"15","author":"K Nosho","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"e40024","DOI":"10.1371\/journal.pone.0040024","article-title":"Clinicopathological significance and prognostic value of DNA methyltransferase 1, 3a, and 3b expressions in sporadic epithelial ovarian cancer","volume":"7","author":"X Bai","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/sj.bjc.6601602","article-title":"Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-gamma in haematopoietic tumour cells","volume":"90","author":"Y Morimoto","year":"2004","journal-title":"Br J Cancer"},{"issue":"55","key":"ref27","doi-asserted-by":"crossref","first-page":"8876","DOI":"10.1038\/sj.onc.1208144","article-title":"Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells","volume":"23","author":"A Satoh","year":"2004","journal-title":"Oncogene"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"e36013","DOI":"10.1371\/journal.pone.0036013","article-title":"Dysregulated recruitment of the histone methyltransferase EZH2 to the class II transactivator (CIITA) promoter IV in breast cancer cells","volume":"7","author":"AD Truax","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ni.1968","article-title":"Lysine methylation of the NF-kappaB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-kappaB signaling","volume":"12","author":"D Levy","year":"2011","journal-title":"Nat Immunol"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrc780","article-title":"NF-kappaB in cancer: from innocent bystander to major culprit","volume":"2","author":"M Karin","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10549-007-9559-y","article-title":"Role of Fra-2 in breast cancer: influence on tumor cell invasion and motility","volume":"107","author":"K Milde-Langosch","year":"2008","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"ref32","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1158\/0008-5472.CAN-11-2209","article-title":"Deficiency in mammalian histone H2B ubiquitin ligase Bre1 (Rnf20\/Rnf40) leads to replication stress and chromosomal instability","volume":"72","author":"SB Chernikova","year":"2012","journal-title":"Cancer Res"},{"issue":"19","key":"ref33","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1101\/gad.1703008","article-title":"The histone H2B-specific ubiquitin ligase RNF20\/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression","volume":"22","author":"E Shema","year":"2008","journal-title":"Genes Dev"},{"issue":"37","key":"ref34","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1038\/sj.onc.1210610","article-title":"Histone deacetylases and cancer","volume":"26","author":"MA Glozak","year":"2007","journal-title":"Oncogene"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.cr.7310149","article-title":"HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics","volume":"17","author":"P Gallinari","year":"2007","journal-title":"Cell Res"},{"issue":"6","key":"ref36","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1002\/jcb.24090","article-title":"HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins","volume":"113","author":"KH Jung","year":"2012","journal-title":"J Cell Biochem"},{"issue":"11","key":"ref37","doi-asserted-by":"crossref","first-page":"e28103","DOI":"10.1371\/journal.pone.0028103","article-title":"Aberrant regulation of HDAC2 mediates proliferation of hepatocellular carcinoma cells by deregulating expression of G1\/S cell cycle proteins","volume":"6","author":"JH Noh","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"ref38","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1096\/fj.04-2303fje","article-title":"Histone deacetylase HDAC8 associates with smooth muscle alpha-actin and is essential for smooth muscle cell contractility","volume":"19","author":"D Waltregny","year":"2005","journal-title":"FASEB J"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1158\/1078-0432.CCR-08-0684","article-title":"Histone deacetylase 8 in neuroblastoma tumorigenesis","volume":"15","author":"I Oehme","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"7415","key":"ref40","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature11316","article-title":"HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle","volume":"489","author":"MA Deardorff","year":"2012","journal-title":"Nature"},{"issue":"8","key":"ref41","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/jmedgenet-2012-100921","article-title":"X-exome sequencing identifies a HDAC8 variant in a large pedigree with X-linked intellectual disability, truncal obesity, gynaecomastia, hypogonadism and unusual face","volume":"49","author":"M Harakalova","year":"2012","journal-title":"J Med Genet"},{"issue":"4","key":"ref42","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0092-8674(02)00861-9","article-title":"Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy","volume":"110","author":"CL Zhang","year":"2002","journal-title":"Cell"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1053\/j.gastro.2009.10.037","article-title":"Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice","volume":"138","author":"EF de Zoeten","year":"2010","journal-title":"Gastroenterology"},{"issue":"12","key":"ref44","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1158\/1078-0432.CCR-10-0395","article-title":"HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth","volume":"16","author":"T Milde","year":"2010","journal-title":"Clin Cancer Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/1471-2407-8-243","article-title":"Differential expression of 12 histone deacetylase (HDAC) genes in astrocytomas and normal brain tissue: class II and IV are hypoexpressed in glioblastomas","volume":"8","author":"AK Lucio-Eterovic","year":"2008","journal-title":"BMC Cancer"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ijc.20395","article-title":"Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients","volume":"112","author":"H Osada","year":"2004","journal-title":"Int J Cancer"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ni.1673","article-title":"The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance","volume":"10","author":"A Villagra","year":"2009","journal-title":"Nat Immunol"},{"issue":"10","key":"ref48","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1182\/blood-2010-08-303701","article-title":"HDAC11 plays an essential role in regulating OX40 ligand expression in Hodgkin lymphoma","volume":"117","author":"D Buglio","year":"2011","journal-title":"Blood"},{"issue":"5","key":"ref49","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/jmg.38.5.285","article-title":"Methylation matters","volume":"38","author":"JF Costello","year":"2001","journal-title":"J Med Genet"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1038\/ncomms5330","article-title":"Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs","volume":"5","author":"GH Liu","year":"2014","journal-title":"Nat Commun"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0139740","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T15:14:00Z","timestamp":1567264440000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0139740"}},"subtitle":[],"editor":[{"given":"Hiromu","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,10,14]]},"references-count":50,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,10,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0139740","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,14]]}}}